Asymchem Completes First USFDA Inspection at Tianjin 4 Site
TIANJIN, China, October 29, 2026 Asymchem has successfully completed its first U.S. Food and Drug Administration (USFDA) Pre-Approval Inspection...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
TIANJIN, China, October 29, 2026 Asymchem has successfully completed its first U.S. Food and Drug Administration (USFDA) Pre-Approval Inspection...
New York, August 6, 2026 WindRose Health Investors, LLC has completed the recapitalization of Verified Clinical Trials, LLC (VCT),...
Toronto, Canada — February 26, 2026 Xtalks has announced an upcoming webinar highlighting how an ecosystem-driven, AI-enabled Electronic Lab...
Grove City, Ohio – October 30, 2025 — Tosoh Bioscience, Inc., a global leader in clinical diagnostics and laboratory...
Lexington, Massachusetts – October 30, 2025 — Rapid Micro Biosystems, Inc. (Nasdaq: RPID), a leader in automated microbial quality...
